Provision of Multidrug-resistant tuberculosis (MDR-TB) and Extensively drug-resistant tuberculosis (XDR-TB) treatment

NHS England are inviting Expressions of Interests from suitably experienced, competent and skilled providers wishing to demonstrate compliance with the requirements as set out in this notice for the provision of Bedaquiline and Delamanid for defined patients with Multidrug-Resistant / Extensively Drug-resistant Tuberculosis . This opportunity was also advertised during December 2015 (OJEU reference: 2015/S243-441645). However, this is an additional notice for the same procurement exercise in order to allow a more r...